{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:51:21Z","timestamp":1747158681725,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ctro.2024.100756","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T16:50:42Z","timestamp":1709225442000},"page":"100756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases"],"prefix":"10.1016","volume":"46","author":[{"given":"Gamze","family":"Ugurluer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Famke L.","family":"Schneiders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-7252","authenticated-orcid":false,"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupesh","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Portelance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-5627","authenticated-orcid":false,"given":"Philip","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav A.","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2725-4807","authenticated-orcid":false,"given":"Spencer","family":"Poiset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian N.","family":"Marschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4669-0436","authenticated-orcid":false,"given":"Giulia","family":"Panza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-8612","authenticated-orcid":false,"given":"Tugce","family":"Kutuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3895-2638","authenticated-orcid":false,"given":"Alessandra","family":"Castelluccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teuta","family":"Zoto Mustafayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Atalar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-2204","authenticated-orcid":false,"given":"Suresh","family":"Senan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9497-7976","authenticated-orcid":false,"given":"Enis","family":"Ozyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2024.100756_b0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","article-title":"Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital","volume":"56","author":"Lam","year":"2002","journal-title":"Clin Endocrinol (oxf)"},{"issue":"5","key":"10.1016\/j.ctro.2024.100756_b0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/cen.14268","article-title":"Presentation, disease progression and outcomes of adrenal gland metastases","volume":"93","author":"Mao","year":"2020","journal-title":"Clin Endocrinol (oxf)"},{"issue":"2","key":"10.1016\/j.ctro.2024.100756_b0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archsurg.134.2.212","article-title":"Laparoscopic adrenalectomy","volume":"134","author":"Barresi","year":"1999","journal-title":"Arch Surg"},{"issue":"12","key":"10.1016\/j.ctro.2024.100756_b0020","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1586\/era.12.125","article-title":"Stereotactic body radiation therapy for metastasis to the adrenal glands","volume":"12","author":"Shiue","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"issue":"7","key":"10.1016\/j.ctro.2024.100756_b0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ctrv.2014.04.001","article-title":"Surgical and ablative therapies for the management of adrenal 'oligometastases' - a systematic review","volume":"40","author":"Gunjur","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"10.1016\/j.ctro.2024.100756_b0030","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1007\/s00464-023-10148-0","article-title":"Risk factors for intraoperative complications, postoperative complications, and prolonged length of stay after laparoscopic adrenalectomy by transperitoneal lateral approach: a retrospective cohort study of 547 procedures","volume":"37","author":"Fouche","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ctro.2024.100756_b0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1748-717X-1-33","article-title":"A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: implications for radiation dose escalation in carcinoma of the pancreas","volume":"1","author":"Singh","year":"2006","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2024.100756_b0040","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.ijrobp.2011.12.073","article-title":"Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy","volume":"83","author":"Liu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ctro.2024.100756_b0045","first-page":"e6457","article-title":"First 500 fractions delivered with a magnetic resonance-guided radiotherapy system: initial experience","volume":"11","author":"Sahin","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ctro.2024.100756_b0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2021.11.024","article-title":"CT-guided versus MR-guided radiotherapy: impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy","volume":"166","author":"Rodriguez","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100756_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109749","article-title":"Tumor volume changes during stereotactic ablative radiotherapy for adrenal gland metastases under MRI guidance","volume":"186","author":"Giraud","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100756_b0060","article-title":"Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk","volume":"39","author":"Hoegen","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100756_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010291","article-title":"Stereotactic MR-guided radiotherapy for adrenal gland metastases: first clinical results","volume":"12","author":"Michalet","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ctro.2024.100756_b0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2022.02.023","article-title":"Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period","volume":"170","author":"van Vliet","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100756_b0075","first-page":"1","article-title":"Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases. phys imaging","volume":"20","author":"van Sornsen de Koste","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100756_b0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2020.07.045","article-title":"Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases","volume":"152","author":"van Sornsen de Koste","year":"2020","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2024.100756_b0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2018.06.002","article-title":"Role of daily plan adaptation in MR-guided stereotactic ablative radiation therapy for adrenal metastases","volume":"102","author":"Palacios","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100756_b0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2021.07.026","article-title":"Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy","volume":"163","author":"Chen","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100756_b0095","article-title":"Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk","volume":"43","author":"Schneiders","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100756_b0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2024.100756_b0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2024.100756_b0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2020.01.017","article-title":"Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients","volume":"107","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2024.100756_b0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2022.01.002","article-title":"Determining planning priorities for SABR for oligometastatic disease: a secondary analysis of the SABR-COMET phase II randomized trial","volume":"114","author":"Van Oirschot","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100756_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109576","article-title":"Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial","volume":"182","author":"Eufemon Cereno","year":"2023","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2024.100756_b0125","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s11255-020-02496-w","article-title":"Prognostic factors after adrenalectomy for adrenal metastasis","volume":"52","author":"Goujon","year":"2020","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.ctro.2024.100756_b0130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ijc.33546","article-title":"Stereotactic or conformal radiotherapy for adrenal metastases: patient characteristics and outcomes in a multicenter analysis","volume":"149","author":"Buergy","year":"2021","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ctro.2024.100756_b0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10585-021-10124-9","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis","volume":"38","author":"Franzese","year":"2021","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.ctro.2024.100756_b0140","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1038\/s41598-020-64770-2","article-title":"Clinical efficacy of stereotactic body radiation therapy (SBRT) for adrenal gland metastases: a multi-center retrospective study from China","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci Rep"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T22:04:40Z","timestamp":1724969080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"alternative-id":["S2405630824000338"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100756","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100756"}}